Li et al., 2016 - Google Patents
Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vectorLi et al., 2016
- Document ID
- 810095451535477854
- Author
- Li X
- Kuang Y
- Huang X
- Zou L
- Huang L
- Yang T
- Li W
- Yang Y
- Publication year
- Publication venue
- International Immunopharmacology
External Links
Snippet
CXCR4 is a member of chemokine receptors and plays a vital role in numerous diseases and cancer processes, which makes the CXCR4/CXCL12 chemotactic axis a potential therapeutic target. In this study, we used lentiviral vectors as a novel technology to produce …
- 101710003734 CXCR4 0 title abstract description 96
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11685789B2 (en) | CD47 antigen-binding molecules | |
| ES2818103T3 (en) | ROR1-specific chimeric antigen receptors and antibodies | |
| EP3273994B1 (en) | Car t-cell therapy directed to lhr for the treatment of solid tumors | |
| US20230029835A1 (en) | Development and application of therapeutic agents for tslp-related diseases | |
| WO2008139202A1 (en) | Neutralizing monoclonal antibody against human dll4 | |
| US20200016201A1 (en) | Chimeric antigen receptors and compositions and methods of use thereof | |
| EP2496604B1 (en) | Canine anti-cd20 antibodies | |
| JP7409669B2 (en) | Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof | |
| CA2981143A1 (en) | Car t-cells for the treatment of b7-h4 expressing solid tumors | |
| WO2019086480A1 (en) | Anti-cd5l antibody and uses thereof | |
| JP2022513008A (en) | Fusion proteins and their use | |
| CN112574311B (en) | Antibody with double MIC binding activity and application thereof | |
| CN114761036A (en) | Anti-canine Fibroblast Activation Protein (FAP) monoclonal antibody cross-reactive with mouse and human FAP | |
| Li et al. | Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector | |
| WO2019110209A1 (en) | Cd47 and bcma/taci antigen-binding molecules | |
| WO2024056098A1 (en) | Nkg2d-nkp46 cell adapter molecule and use thereof | |
| WO2024056097A1 (en) | Use of nkg2d-based cell adapter molecule in removal of aging cells | |
| Salehi-Lalemarzi et al. | Cloning and stable expression of cdna coding for platelet endothelial cell adhesion molecule-1 (pecam-1, cd31) in nih-3t3 cell line | |
| CN114573702A (en) | Development and application of novel tumor adaptor treatment drug | |
| Liu et al. | Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4 | |
| CN117510636B (en) | GPRC5D antibody and application thereof | |
| WO2023088429A1 (en) | SIRPα VARIANT AND USE THEREOF | |
| Shafaghat et al. | Preparation of proper immunogen by cloning and stable expression of cDNA coding for human hematopoietic stem cell marker CD34 in NIH-3T3 mouse fibroblast cell line | |
| WO2023088295A1 (en) | Multi-specific antibody and pharmaceutical use thereof | |
| Zhang et al. | Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3 |